[Immunological variations after thymic stimulation with special reference to IL2-RS in patients operated for neoplasms].
The paper reports a study which was carried out to assess immunological function by assaying IL2 in cancer-operated patients treated with thymostimulin. The results of the study show that, used in normally fed, immunodepressed patients, this immunomodulator is able to normalise levels of lymphocyte subpopulations and to bring serum concentrations of IL2-RS to the levels of normoergic patients.
Ricci
E
E
Istituto di Patologia Chirurgica, Università degli Studi di Torino.
Giaccone
M
M
Pecchio
F
F
Lale-Murix
E
E
De Simone
M
M
Nano
M
M
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000276:immunology / Q000601:surgery*; D006801:Humans; D007376:Interleukin-2 / Q000032:analysis*; D016131:Lymphocyte Subsets / Q000276:immunology; D008297:Male; D008875:Middle Aged; D013949:Thymus Extracts / Q000494:pharmacology*; D013997:Time Factors
D000276:Adjuvants, Immunologic; D007376:Interleukin-2; D013949:Thymus Extracts; C031407:thymostimulin
Variazioni immunologiche dopo stimolazione timica con particolare riguardo all'IL2-RS, nel paziente operato per neoplasia.